New memory test for ECT patients being adapted for turkish speakers
NCT ID NCT07527234
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to translate and test a cognitive assessment tool called the ECCA (Electroconvulsive Therapy Cognitive Assessment) into Turkish. The ECCA is designed to measure memory, attention, and other thinking skills that can be affected by electroconvulsive therapy (ECT), a treatment for severe depression and other mental health conditions. Researchers will enroll 90 patients aged 18-65 who are scheduled for ECT, and compare the Turkish ECCA with other standard cognitive tests to see if it is a reliable and valid tool.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could provide a more accurate way to monitor memory and thinking problems in people undergoing ECT, helping doctors make better treatment decisions.
- What could go wrong
- This is a small, early-stage study focused on translating and testing a questionnaire, not on treating a disease. The tool may not prove more useful than existing tests.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 90 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jul 2025
- Expected to finish
-
Nov 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
all patients receiving ect
- Ages
-
18 to 65 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria:A sample of 90 patients, aged 18-65, had an indication for ECT according to DSM-5 diagnostic criteria. \- Exclusion Criteria:Intellectual disability, cognitive impairments, history of neurological disease, substance abuse, illiteracy, diagnosis of dementia. \-
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cognitive assessment are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Pamukkale Univercity
Denizli, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a translated brain test catch hidden thinking problems after stroke?
- Could a daily mushroom help shield aging brains?
- Could a nerve-stimulation device help the brain learn again after a stroke?
- Talking it out: new program eases stigma and fear for ECT patients
- Can VR games help stroke survivors think and function better?
- Pecans vs. pretzels: a nutty brain battle for seniors with memory loss